$2.47
-3.5%American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.
Chief Executive Officer
Chief Financial Officer
Compensation
$508,071
Chief Human Resource Officer
Chief Information Officer, General Counsel & Secretary
Compensation
$398,244
Chief Transformation Officer
Director of Corporate Communications
Director of Investor Relations
Senior Vice President of Strategy, Marketing & R&D
Senior Vice President of Supply Chain & Operations
Vice President & Director of Technology
During the last 12 months, insiders have purchased $194K and sold $44K worth of AVD shares, resulting in $151K of net buying activity.
65.0K
184.90K
1.1K
11.45K
+173K
+$173K
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
2.0K
9.34K
6.0K
32.10K
-23K
-$23K
Gottschalk Patrick E
Director
$185K
Kaye Douglas
Officer: Chief Executive Officer
$9K
Eilers Peter
Officer: See Remarks
$32K
Bennett John Mason
Officer: See Remarks
$11K
Strong bullish signal with $151K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
2 insider buyers and 2 sellers. Equal participation suggests mixed or neutral insider views.
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
AVD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | June 03, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | May 29, 2025 | May 29, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 25, 2024 | June 06, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 25, 2023 | April 25, 2023 | ||
DEF 14A DEF 14A 2021 N/A | April 21, 2021 | June 02, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 21, 2020 | June 03, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 22, 2019 | June 05, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 23, 2018 | June 06, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 21, 2017 | June 06, 2017 | 2017 | |
DEF 14A DEF 14A 2016 N/A | April 25, 2016 | June 08, 2016 | 2016 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.